NCT04511013 2025-09-11A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain MetastasesSWOG Cancer Research NetworkPhase 2 Recruiting112 enrolled